"Triglycerides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D014280
|
| MeSH Number(s) |
D10.351.801
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triglycerides".
Below are MeSH descriptors whose meaning is more specific than "Triglycerides".
This graph shows the total number of publications written about "Triglycerides" by people in this website by year, and whether "Triglycerides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 2 | 4 | 6 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 2 | 1 | 3 |
| 2000 | 1 | 3 | 4 |
| 2001 | 4 | 10 | 14 |
| 2002 | 3 | 4 | 7 |
| 2003 | 3 | 11 | 14 |
| 2004 | 4 | 11 | 15 |
| 2005 | 4 | 6 | 10 |
| 2006 | 4 | 12 | 16 |
| 2007 | 2 | 7 | 9 |
| 2008 | 9 | 8 | 17 |
| 2009 | 6 | 10 | 16 |
| 2010 | 3 | 13 | 16 |
| 2011 | 5 | 14 | 19 |
| 2012 | 5 | 19 | 24 |
| 2013 | 10 | 19 | 29 |
| 2014 | 9 | 18 | 27 |
| 2015 | 5 | 10 | 15 |
| 2016 | 7 | 7 | 14 |
| 2017 | 4 | 10 | 14 |
| 2018 | 4 | 5 | 9 |
| 2019 | 7 | 11 | 18 |
| 2020 | 1 | 10 | 11 |
| 2021 | 5 | 6 | 11 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 5 | 5 |
| 2024 | 6 | 6 | 12 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triglycerides" by people in Profiles.
-
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025 Mar 04; 14(5):e038656.
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
-
Characterising the lipid profile of paediatric patients with anomalous aortic origins of a coronary artery. Cardiol Young. 2025 Feb; 35(2):311-316.
-
Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2. J Pediatr. 2025 Jan; 276:114298.
-
Comparative and combination study of simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients. Pak J Pharm Sci. 2024 Sep; 37(5):1033-1041.
-
Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024 Aug 01; 9(8):741-747.
-
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial. JAMA Cardiol. 2024 Jul 01; 9(7):620-630.
-
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med. 2024 09 12; 391(10):913-925.
-
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia. N Engl J Med. 2024 09 12; 391(10):899-912.
-
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome. N Engl J Med. 2024 05 16; 390(19):1781-1792.